文献速递妇科

上皮性卵巢癌生存轨迹的预测因素:基于SEER的分析

Predictors of survival trajectories among women with epithelial ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2019-12-12

该研究利用SEER项目2004-2016年诊断为上皮性卵巢癌的35,868例女性数据,采用扩展Cox比例风险回归分析患者和肿瘤特征与各生存时间区间(<3年、3-<6年、6-<9年、9-<13年)全因死亡率的关联。结果显示,多数特征在诊断后早期与死亡率关联更强,随生存时间延长而减弱;年龄>70岁在<3年和≥9年区间均显示高死亡风险,非西班牙裔亚裔/太平洋岛民在≥9年区间与死亡率呈更明显的负相关。

要点

  • 诊断时年龄、婚姻状况、种族/民族、分期和手术与死亡率的关联在短期生存期更强,随生存时间延长而减弱。
  • 年龄>70岁在诊断后<3年和≥9年两个时间区间均观察到高死亡风险。
  • 非西班牙裔亚裔/太平洋岛民在诊断后≥9年与死亡率呈更明显的负相关。

核心结论

  • 大多数患者和肿瘤特征与死亡率的关联在诊断后最初几年更强,但随生存时间延长影响逐渐减弱。
  • 鉴于这种减弱效应,识别随着卵巢癌患者生存轨迹推进而影响死亡风险的因素至关重要。

研究设计与样本

  • 研究从SEER项目提取2004-2016年诊断为上皮性卵巢癌的35,868例女性数据。
  • 采用扩展Cox比例风险回归估计患者和肿瘤特征与各生存时间区间(t<3、3≤t<6、6≤t<9、9≤t<13年)全因死亡率的总体及组织学类型特异性关联。

主要发现

  • 诊断时年龄、婚姻状况、种族/民族、分期和手术与死亡率的关联在短期生存期更强,随生存时间延长而减弱。
  • 年龄>70岁在t<3年和t≥9年区间均观察到高死亡风险。
  • 非西班牙裔亚裔/太平洋岛民在诊断后t≥9年与死亡率呈更明显的负相关。
  • 在高级别浆液性癌(HGSC)中观察到类似关联,但大多数特征的减弱效应不明显。
  • 在非HGSC中,分期和种族/民族的死亡关联更明显,主要涉及非西班牙裔亚裔/太平洋岛民。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although ovarian cancer is a deadly disease, approximately a third of women survive ≥9 years after diagnosis. The factors associated with achieving long-term survival are not well understood. In this study, data from the Surveillance, Epidemiology, and End Results (SEER) program were used to determine predictors of survival trajectories among women with epithelial ovarian cancer and across histotype (high-grade serous carcinoma (HGSC) and non-HGSC). METHODS: Data on 35,868 women diagnosed with epithelial ovarian cancer in 2004-2016 were extracted from SEER. Extended Cox proportional hazards regression was used to estimate overall and histotype-specific associations between patient and tumor characteristics and all-cause mortality within each survival time (t) interval (t < 3, 3 ≤ t < 6, 6 ≤ t < 9, and 9 ≤ t < 13 years). RESULTS: Age at diagnosis, marital status, race/ethnicity, stage, and surgery were more strongly associated with mortality in the short-term survival period, and these associations waned with increasing survival time. Exceptions to this pattern were age >70 years at diagnosis, where a high risk of mortality was observed in both the t < 3 and t ≥ 9 year time periods, and non-Hispanic Asian/Pacific Islanders, where a more pronounced inverse association with mortality was observed in t ≥ 9 years after diagnosis. Similar associations were observed for HGSC, although the waning effect was not apparent for most characteristics. Mortality associations for non-HGSC were more pronounced for stage and race/ethnicity, primarily for non-Hispanic Asian/Pacific Islanders. CONCLUSIONS: Most patient and tumor characteristics were more strongly associated with mortality in the years following diagnosis, but have declining impact with increasing survival time. Given this waning effect, it is critical to identify factors impacting risk of mortality as ovarian cancer patients advance through the survival trajectory.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Peres LC, Sinha S, Townsend MK, et al. Predictors of survival trajectories among women with epithelial ovarian cancer. Gynecol Oncol. 2019. PMID: 31839342. doi:10.1016/j.ygyno.2019.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。